Chinese (SSE) Healthcare Services Industry Analysis
UpdatedMar 21, 2023
DataAggregated Company Financials
Companies39
- 7D-3.1%
- 3M6.0%
- 1Y4.7%
- YTD1.1%
The Healthcare Services is pretty flat in the last 7 days, but Shanghai Pharmaceuticals Holding has stood out, gaining 6.8%. As for the the longer term, the industry is up 10% over the past 12 months. Looking forward, earnings are forecast to grow by 31% annually.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Mar 2023 | CN¥813.9b | CN¥907.3b | CN¥26.8b | 30.3x | 30.4x | 0.9x |
| Thu, 16 Feb 2023 | CN¥862.8b | CN¥906.0b | CN¥26.4b | 32x | 32.7x | 1x |
| Sat, 14 Jan 2023 | CN¥851.5b | CN¥905.7b | CN¥26.4b | 30.2x | 32.3x | 0.9x |
| Mon, 12 Dec 2022 | CN¥799.1b | CN¥905.7b | CN¥26.4b | 30.1x | 30.3x | 0.9x |
| Wed, 09 Nov 2022 | CN¥745.7b | CN¥905.7b | CN¥26.4b | 30.9x | 28.3x | 0.8x |
| Fri, 07 Oct 2022 | CN¥655.4b | CN¥842.5b | CN¥23.8b | 21x | 27.5x | 0.8x |
| Sun, 04 Sep 2022 | CN¥680.3b | CN¥842.5b | CN¥23.8b | 25.5x | 28.6x | 0.8x |
| Tue, 02 Aug 2022 | CN¥744.0b | CN¥840.8b | CN¥24.0b | 32x | 31x | 0.9x |
| Thu, 30 Jun 2022 | CN¥737.0b | CN¥839.0b | CN¥23.9b | 26.8x | 30.8x | 0.9x |
| Sat, 28 May 2022 | CN¥655.1b | CN¥839.0b | CN¥23.9b | 25.4x | 27.4x | 0.8x |
| Mon, 25 Apr 2022 | CN¥648.7b | CN¥821.5b | CN¥27.6b | 23.9x | 23.5x | 0.8x |
| Wed, 23 Mar 2022 | CN¥647.2b | CN¥810.3b | CN¥26.5b | 29.1x | 24.4x | 0.8x |
| Fri, 18 Feb 2022 | CN¥660.8b | CN¥806.8b | CN¥26.8b | 27.7x | 24.7x | 0.8x |
| Sun, 16 Jan 2022 | CN¥721.1b | CN¥805.6b | CN¥26.7b | 27.4x | 27x | 0.9x |
| Tue, 14 Dec 2021 | CN¥755.0b | CN¥804.6b | CN¥26.6b | 24x | 28.4x | 0.9x |
| Thu, 11 Nov 2021 | CN¥748.1b | CN¥802.0b | CN¥26.5b | 23.3x | 28.2x | 0.9x |
| Sat, 09 Oct 2021 | CN¥805.1b | CN¥793.2b | CN¥27.2b | 24.1x | 29.6x | 1x |
| Mon, 06 Sep 2021 | CN¥745.0b | CN¥791.7b | CN¥27.1b | 24.6x | 27.5x | 0.9x |
| Wed, 04 Aug 2021 | CN¥885.7b | CN¥791.5b | CN¥27.0b | 26.9x | 32.8x | 1.1x |
| Sat, 08 May 2021 | CN¥939.3b | CN¥756.8b | CN¥25.2b | 28.4x | 37.3x | 1.2x |
| Tue, 09 Feb 2021 | CN¥883.8b | CN¥717.0b | CN¥19.4b | 24.1x | 45.6x | 1.2x |
| Mon, 02 Nov 2020 | CN¥809.1b | CN¥694.4b | CN¥13.8b | 20.1x | 58.7x | 1.2x |
| Thu, 06 Aug 2020 | CN¥749.6b | CN¥677.7b | CN¥12.0b | 23.5x | 62.6x | 1.1x |
| Sun, 10 May 2020 | CN¥554.1b | CN¥684.8b | CN¥9.0b | 17.4x | 61.7x | 0.8x |
Price to Earnings Ratio
58.6x
Current Industry PE
- Investors are pessimistic on the Chinese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 31.1x which is lower than its 3-year average PE of 38.8x.
- The industry is trading close to its 3-year average PS ratio of 0.98x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 44% per year over the last three years.
- Revenues for these companies have grown 9.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -1.65% | |
| Healthcare | -3.57% | |
| Healthcare Services | -3.10% | |
| Managed Healthcare | 0% | |
| Healthcare Distributors | -1.89% | |
| Healthcare Services | -3.91% | |
| Healthcare Facilities | -4.02% | |
Industry PE
- Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 194x.
- Analysts are expecting annual earnings growth of 35.3%, which is higher than its past year's earnings growth of 19.4% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 17.2x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 45% over the next 5 years.
- This is better than its past earnings decline of 6.4% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 20% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 28 China National Accord Medicines | CN¥45.70 | 9.1% +CN¥1.6b | 38.6% | PE13.2x | |
| 603882 Guangzhou Kingmed Diagnostics Group | CN¥81.79 | 3.6% +CN¥1.3b | 9.0% | PE12.8x | |
| 300244 Dian Diagnostics GroupLtd | CN¥26.35 | 4.3% +CN¥677.0m | -5.1% | PE7x | |
| 601607 Shanghai Pharmaceuticals Holding | CN¥20.45 | 0.5% +CN¥369.8m | -18.0% | PE13.9x | |
| 950 C.Q. Pharmaceutical Holding | CN¥5.62 | 3.9% +CN¥366.1m | -11.9% | PE8.9x |